National Women’s Health Day is celebrated on Saturday 22 April and the Onda Foundation, the National Observatory on Women’s and Gender Health, is relaunching its dedicated (H)-Open Week, with free visits to over 250 ‘Pink Stamp’ hospitals. The initiative, now in its eighth edition, is scheduled from 17 to 22 April with the aim of promoting information, prevention and treatment for women. All the services offered can be consulted on the website www.bollinirosa.it, with information on dates, times and booking methods. It is possible to select the region and province of interest, to view the list of participating hospitals and consult the services offered.
The structures of the Pink Bollini network that have joined the Open Week will offer free clinical, diagnostic and information services in presence and remotely in the specialist areas of cardiology, coloproctology, dermatology, diabetology, dietetics and nutrition, endocrinology and metabolic diseases, gynecology and obstetrics, reproductive medicine, neurology, gynecological oncology, medical oncology, pulmonology, psychiatry, rheumatology, breastology, urology and in the context of courses dedicated to violence against women, lists Onda. The initiative is supported by various sponsors and sponsored by scientific societies of the various disciplines.
“The success that the (H)-Open week on women’s health continues to achieve reminds us how fundamental it is to continue to deal with women’s health as a value in itself and as a social value, inviting us to act more and more concretely – says Francesca Merzagora, president of the Onda Foundation – With the eighth edition of the (H)-Open week on women’s health, born on the occasion of the establishment of the National Women’s Health Day wanted by the then Minister of Health Beatrice Lorenzin, the Onda Foundation renews the its commitment to women’s health by offering a week of free services in the hospitals participating in the initiative, such as visits and instrumental tests, telephone consultations, remote events and interviews, info points and the distribution of information material to bring the female population closer to increasingly precocious diagnoses and personalized treatment pathways”.